Skip to main
SBRA

SBRA Stock Forecast & Price Target

SBRA Analyst Ratings

Based on 10 analyst ratings
Buy
Strong Buy 10%
Buy 40%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

Sabra Health Care REIT Inc. is experiencing a positive outlook due to continued improvements in occupancy and rent coverage, bolstering its overall revenue generation from its portfolio of healthcare real estate. The anticipated recovery in the seniors housing managed portfolio is expected to enhance the company’s leverage profile, positioning it well for future growth opportunities. Additionally, the healthcare real estate demand drivers remain favorable, complemented by Sabra's above-average RIDEA exposure, which is likely to further strengthen its financial performance.

Bears say

Sabra Health Care REIT faces challenges stemming from unpredictable operator performance, with many operators struggling to meet rent obligations amid an inflationary cost environment. Additionally, the company's leverage position is higher than several peers, which, coupled with its trading near the high end of its 10-year valuation range, constrains potential for immediate earnings growth from acquisitions. Lastly, the current cost of equity suggests limited room for future earnings accretion, further contributing to a negative outlook for the stock.

SBRA has been analyzed by 10 analysts, with a consensus rating of Buy. 10% of analysts recommend a Strong Buy, 40% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Sabra Health Care and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Sabra Health Care (SBRA) Forecast

Analysts have given SBRA a Buy based on their latest research and market trends.

According to 10 analysts, SBRA has a Buy consensus rating as of Feb 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $21.40, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $21.40, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Sabra Health Care (SBRA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.